301108SZSE

Jieya Co., Ltd.

洁雅股份

301108

Shenzhen Stock Exchange

Follow
45 announcements tracked· Last: May 20, 2026

Key Financials

Revenue¥192.2M
Net Profit¥10.3M
ROE0.54%
Debt Ratio21.19%
Monetary Funds¥471.8M
Receivables¥203.4M
Total Shares112.6M

Announcements

45 total

Announcement on the progress of obtaining government subsidies

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Implementation of the 2025 Annual Dividend Distribution

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on obtaining government subsidies

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Legal Opinion on the 2025 Annual Shareholder Meeting of Tongling Jieya Biotechnology Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement of the Resolutions from the 2025 Annual Shareholder Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Legal opinion on the invalidation of part of the granted but unvested restricted stocks related to Tongling Jieya Biotechnology Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement on invalidating part of the granted but unvested restricted stocks

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on applying for a comprehensive credit limit from the bank

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the expected daily related party transactions for 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement of the resolution of the 9th meeting of the sixth board of directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Q1 2026 report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Departure of Senior Management Personnel

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Guorong Securities Co., Ltd. Special Verification Report on Tongling Jieya Biotechnology Co., Ltd.'s 2025 Fundraising Storage, Management, and Usage

Share Repurchase CompletionShareholder Share IncreaseShare Pledge

Announcement on the Reappointment of the Audit Institution for 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Board of Directors' Work Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 General Manager's Work Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2026 Compensation Plan for Directors and Senior Management

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Independent Director's Work Report (He Wenlong)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Independent Director's Work Report (Chen Yan)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Independent Director's Work Report (Zhao Bo)

Convertible BondsShareholding Change DisclosureCapital Reduction

Announcement on Holding the 2025 Online Performance Briefing

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Internal Control Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Internal Control Evaluation Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Compensation Management System for Directors and Senior Management

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Guorong Securities Co., Ltd. Verification Opinion on Tongling Jieya Biotechnology Co., Ltd.'s Use of Part of the Over-raised Funds to Permanently Supplement Working Capital

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement on the Use of Part of the Over-raised Funds to Permanently Supplement Working Capital

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notice of the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Resolution Announcement of the Eighth Meeting of the Sixth Board of Directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Authorizing the Board of Directors to Formulate the 2026 Mid-term Dividend Plan

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Profit Distribution Plan for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Report on the Storage, Management, and Usage of Fundraising for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Verification Report on the Storage, Management, and Usage of Fundraising

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

2025 Evaluation Report on the Performance of the Accounting Firm

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Report of the Board of Directors' Audit Committee on the Supervision Responsibilities of the Accounting Firm

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Explanation on Non-operating Fund Occupation and Other Related Fund Transactions

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Summary Table of Non-operating Fund Occupation and Other Related Fund Transactions for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Report on the Self-examination of Independent Directors' Independence

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Summary of the 2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Establishing a Subsidiary in Egypt and Investing in the Construction of a Production Base

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the completion of the cancellation of some special accounts for raised funds

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Cancelling Dedicated Settlement Accounts for Some Raised Fund Wealth Management Products

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Completion of Industrial and Commercial Change Registration and Issuance of New Business License for Wholly-Owned Subsidiary

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Pre-disclosure Announcement of Share Reduction Plan by Shareholders Holding Over 5% and Their Concerted Parties

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notes & Comments

Sign in to leave a comment or private note.

Loading…